Results 11 to 20 of about 25,171 (251)

Second edition ICCR dataset for testicular germ cell tumours: a reporting guide for histopathological diagnosis of orchiectomy specimens. [PDF]

Histopathology
The current 2nd edition Orchiectomy dataset offers a rigorously validated, internationally developed checklist that supports high‐quality, standardised reporting and promotes clinical confidence across diverse healthcare settings. All ICCR datasets are freely available to the global pathology community via the ICCR website ([www.iccr‐cancer.org](http://
Bremmer F, Webster F, Daugaard G, Hamilton RJ, Idrees MT, Kao CS, Miyai K, Raspollini MR, Srigley JR, Tickoo S, Yilmaz A, Wagner T, Berney DM.   +12 more
europepmc   +2 more sources

Giant testicular germ-cell tumours-An analysis of relative incidence and clinical features based on a clinical case series and a survey of the literature. [PDF]

BJUI Compass
Abstract Objectives This work aimed to document four new cases with giant testicular germ cell tumour (GCT) and to evaluate their relative incidence and clinical characteristics based on a literature survey. Despite the well‐established trend over time towards declining tumour sizes in testicular GCTs, giant testicular tumours (>15 cm in diameter) are ...
Angerer M, Harms AC, Wülfing C, Dieckmann KP.   +3 more
europepmc   +2 more sources

Thymic seminoma [PDF]

Indian Journal of Medical and Paediatric Oncology, 2009
AbstractThymic seminoma is a rare clinical entity. We report a case of an 18-year-old male patient who presented with chest pain, dyspnea, dysphagia of 1-month duration. Contrast-enhanced computer tomogram of chest showed an anterior mediastinal mass. He was subjected to thoracotomy and excision of the mass. Histopathology examination revealed seminoma
Kannan, J., Karkuzhali, P., Lakshminarasimhan, S.   +2 more
openaire   +2 more sources

CHARACTERISTIC CHEMOTHERAPY RESPONSE OF TESTICULAR CANCER PATIENTS IN TERTIARY HOSPITAL

Jurnal Urologi Indonesia, 2022
Objective: The purpose of this study was to determine the correlation of testicular tumor markers on the success of chemotherapy in my institution.
Dio Mafazi Fabrianta, Kurnia Penta Seputra, Besut Daryanto   +2 more
doaj   +1 more source

Assessment of new prognostic risk models for recurrence in patients with clinical stage I seminoma. [PDF]

BJU Int
Objectives To evaluate two new prognostic risk models aimed at improving clinical decision‐making in patients with clinical stage (cS) I seminomatous testicular germ cell tumours (GCTs), 5%–30% of whom experience recurrence during surveillance after orchiectomy and may benefit from adjuvant therapy.
Strauch A, Schoch J, Hellmich M, Schmelz H, Nestler T.   +4 more
europepmc   +2 more sources

CDKN2AIP-induced cell senescence and apoptosis of testicular seminoma are associated with CARM1 and eIF4β

Acta Biochimica et Biophysica Sinica, 2022
Testicular seminoma is a relatively rare tumor which is mostly detected in male population aged from 15 to 35 years old. Although several molecular biomarkers have been identified to be associated with testicular seminoma pathogenesis, the exact ...
Cao Yuming, Chen Zhenlie, Qin Zihan, Qian Kaiyu, Liu Tongzu, Zhang Yuanzhen   +5 more
doaj   +1 more source

Single-Cell RNA Sequencing of Metastatic Testicular Seminoma Reveals the Cellular and Molecular Characteristics of Metastatic Cell Lineage

Frontiers in Oncology, 2022
BackgroundTesticular cancer is the most common solid malignancy in young men. Given the many histological classifications of testicular tumors, seminoma is one of the most treatable cancers.
Linjian Mo, Linjian Mo, Zhenyuan Yu, Zhenyuan Yu, Yufang Lv, Yufang Lv, Jiwen Cheng, Haibiao Yan, Wenhao Lu, Wenhao Lu, Cheng Su, Cheng Su, Qiang Ling, Qiang Ling, Zengnan Mo, Zengnan Mo   +15 more
doaj   +1 more source

Anaplastic seminoma [PDF]

Cancer, 1977
Eight patients with the diagnosis of anaplastic seminoma of the testicle were treated during the megavoltage era from January 1959 to January 1976. Two patients with Stage I disease and one patient with Stage IV disease have died from their malignancy.
M, Kademian, A, Bosch, W L, Caldwell, W, Jaeschke   +3 more
openaire   +2 more sources

Laparoscopic Bilateral Nerve-Sparing Retroperitoneal Lymph Node Dissection for Testicular Cancer After Chemotherapy. [PDF]

Int J Urol
ABSTRACT Objectives Nerve‐sparing techniques are commonly used in retroperitoneal lymph node dissection (RPLND) for patients with testicular cancer to preserve postoperative ejaculation. Laparoscopic RPLND is applicable to small residual masses; however, nerve‐sparing techniques remain challenging.
Hatano K, Ishizuya Y, Nakamura Y, Kawamura M, Nakazawa S, Ueda N, Hayashi T, Yamamoto Y, Takezawa K, Mitsunari K, Kato T, Kakuta Y, Kawashima A, Fukuhara S, Imamura R, Nonomura N.   +15 more
europepmc   +2 more sources

Androgen receptor polymorphisms and testicular cancer risk [PDF]

, 2015
Testicular cancer (TC) is currently the most common malignant solid tumour in Caucasian males aged 15-39 years. Epidemiological evidence suggests that its onset may be due to an imbalance in the action of steroidal sex hormones and their receptors.
CARLINI, TANIA, F. Rizzo, GANDINI, Loredana, GIANNANDREA, FABRIZIO, GRASSETTI, Daniele, LENZI, Andrea, LOMBARDO, Francesco, MASCIANDARO, PAOLA, PAOLI, Donatella, V. Figura   +9 more
core   +1 more source